NYSE:BHC (Canada) Also Trade In: Canada Germany Mexico Switzerland UK

Bausch Health Companies Inc $ 17.19 -0.19 (-1.09%)

On watch
Volume:
3,986,241
Avg Vol (1m):
4,651,104
Market Cap $:
6.13 Bil
Enterprise Value $:
30.29 Bil
P/E (TTM):
0.00
P/B:
12.55
Warning! GuruFocus has detected 6 Severe warning signs with BHC. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

Bausch Health Companies Inc News and Headlines -

GuruFocus Articles Total 411
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 21

Guru stock highlight

Bausch Health Companies Inc. ("Bausch")

In early August, Bausch Health Companies Inc. (BHC) announced that it is planning to spin off its eye care business, Bausch + Lomb, into an independent publicly traded company. This will allow the company to concentrate on its gastroenterology, aesthetics/dermatology, neurology and international pharma business.

Chairman and CEO Joseph Papa said, "We've looked at the value of our pure health companies like Alcon and Cooper and believe that Bausch + Lomb would compare very favorably when investors have an opportunity to make a judgment about the relative value of the stand-alone business".

Comparables like Cooper

157 Views    Sydnee Gatewood    2020-09-08 21:12
Discussion of markets and holdings

August 25, 2020

Dear Unitholders of Chou Associates Fund,

The net asset value per unit ("NAVPU") of a Series A unit of Chou Associates Fund at June 30, 2020 was $73.09 compared to $103.28 at December 31, 2019, a decrease of 29.2%; during the same period, the S&P 500 Total Return Index increased 1.7% in Canadian dollars. In U.S. dollars, a Series A unit of Chou Associates Fund decreased by 32.3% while the S&P 500 Total Return Index decreased 3.1%.

The table shows our one-year, three-year, five-year, 10-year, 15-year and 20-year annual compound rates of return.

120 Views    Sydnee Gatewood    2020-09-08 21:06
Merger arbitrage specialist releases 2nd-quarter portfolio

John Paulson (Trades, Portfolio), head of investment firm Paulson & Co., disclosed his second-quarter portfolio earlier this month.

With the long-term goal of capital preservation, above-average returns and low correlation to the market, the guru's New York-based firm specializes in event-driven arbitrage strategies, including merger arbitrage, bankruptcy reorganizations and distressed credit.

Sticking to these criteria, the investor revealed he established four new positions during the quarter, exited seven stocks and added to or reduced a number of other holdings. Notable transactions included the addition of TD Ameritrade Holding Corp. (AMTD) to the portfolio, as well as significant

278 Views    Sydnee Gatewood    2020-08-25 16:30
Canadian guru releases portfolio updates, including major Berkshire reduction

Francis Chou (Trades, Portfolio), the manager of Chou Associates, recently disclosed the firm's portfolio updates for the second quarter of 2020, which ended on June 30.

While working as a telephone repairman, Chou was introduced to the books written by Benjamin Graham, after which he started an investment club with several of his coworkers in 1981. In 1984, he left his old job for a position as a retail analyst at GW Asset Management, where he met Prem Watsa (Trades, Portfolio), the future Fairfax CEO. Chou turned the investment club into Chou Associates in

347 Views    Margaret Moran    2020-08-24 22:14
The veteran investor also reflects on principles to embrace

Pershing Square founder Bill Ackman (Trades, Portfolio) has achieved phenomenal levels of success during his time on Wall Street. However, it hasn’t always been a straight line up, with the activist investor suffering a number of major setbacks, chiefly from his positions in Herbalife (HLF) - on the short side - and Valeant, which is now Bausch Health Companies (BHC) - on the long side. In a recent interview with Bloomberg, Ackman shared why he chose to become an activist investor discssed several investing principles.

Why be an activist investor?

Ackman started out as a

136 Views    Stepan Lavrouk    2020-06-29 21:37
Canadian guru releases portfolio. Sells include major Berkshire bank holding Bank of America.

Francis Chou (Trades, Portfolio), manager of Chou Associates, disclosed this week that he curbed his holdings in DaVita Inc. (DVA), Bausch Health Companies Inc. (BHC), JPMorgan Chase & Co. (JPM) and Bank of America Corp. (BAC) during the first quarter.

Chou, who met Fairfax Financial Holdings Ltd. (TSX:FFH) CEO Prem Watsa (Trades, Portfolio) in the 1980s, said that some of his key investing tips include buying bargains and thinking independently. Chou’s investing process emphasizes the assessment of a company’s balance sheet, cash flow characteristics, profitability, industry position, special strengths, future growth potential and management

1010 Views    James Li    2020-05-22 21:46
An overview of the guru's top 5 buys

Mario Gabelli (Trades, Portfolio), founder of GAMCO Investors, released his portfolio for the first quarter of 2020. The top five buys included Amazon.com Inc. (AMZN), DuPont de Nemours Inc. (DD), Baush Health Companies Inc. (BHC), Edgewell Personal Care Co. (EPC) and Evergy Inc. (EVRG).

Gabelli currently manages a portfolio of 848 stocks, with 34 new positions added this quarter. The portfolio is valued at $8.46 billion with a 3% turnover rate. Gabelli focuses on investing in undervalued stocks that, backed by research, show the potential for growth.

Portfolio overview

Gabelli's top holdings were Sony Corp (SNE) with

262 Views    Graham Griffin    2020-05-18 20:27
The activist guru's recovery is a lesson for everyone

I've been following Bill Ackman (Trades, Portfolio) carefully over the past several years.

Ackman was once considered to be one of the best investors in the world, but in the wake of the Valeant scandal, he lost this crown.

The hedge fund manager has been on a voyage of discovery since then. He's reduced his staff, moved his office and reconsidered his approach to investing, all in the hopes of being able to turn around his performance.

It is essential to look at these scenarios because they are great case studies for regular investors. After all, the

2128 Views    Rupert Hargreaves    2020-01-06 19:27
Managers who are outstanding capital allocators are vital to achieving long-term investment results

When we control a company we get to allocate capital, whereas we are likely to have little or nothing to say about this process with marketable holdings. This point can be important because the heads of many companies are not skilled in capital allocation.

Their inadequacy is not surprising. Most bosses rise to the top because they have excelled in an area such as marketing, production, engineering, administration or, sometimes, institutional politics. Once they become CEOs, they face new responsibilities. They now must make capital allocation decisions, a critical job that they may have never tackled and that

814 Views    Thomas Macpherson    2019-12-19 17:56
The number of pharmaceutical and biotechnology companies seeking Chapter 11 protection has nearly tripled the 10-year average in 2019 and is expected to continue to rise

The growing number of bankruptcies among biotech companies should send shudders through investors. And a number of companies, some with prominent names, could be joining this dubious list of business failures.

A Nov. 19 article in BioPharma Dive reported that 11 biotech companies have declared bankruptcy this year. That's nearly three times the average number who sought the shield in the past 10 years, according to the firm Bankruptcy Data.

The highest-profile filing was not by a biotech, but by pain management company Purdue Pharma, which was hit with a wave of lawsuits for its role in fueling

482 Views    Barry Cohen    2019-11-19 21:54
Gildan Activewear, Gap make the list

According to the GuruFocus All-in-One Screener, the following companies have high business predictability ratings and a wide margin of safety.

Gildan Activewear

Gildan Activewear Inc. (GIL) has a business predictability rank of five out of five stars and, according to the discounted cash flow calculator, a 13.96% margin of safety at an average price of $27.8 per share.

7ce6b5a9317327e23ede2f43c7445b5a.png

The company, which manufactures T-shirts, fleece, socks and underwear, has a market cap of $5.67 billion and an enterprise value of $6.66 billion. Over the past five years, its revenue has grown 14.60% and its

139 Views    Tiziano Frateschi    2019-10-24 18:59
Bausch Health Companies tops the list

According to the GuruFocus All-In-One Screener as of Tuesday, the following health care stocks are popular among gurus.

Masimo Corp. (MASI) is held by six gurus

The Irvine, California-based medical device company has a market cap of $7.63 billion. Its revenue of $895 million has risen 11.90% over a 10-year period.

40c8c2ae57dfb6f4ed15ddc61dbb9ee8.png

The stock is trading with a price-book ratio of 7.50. The share price of $149 is 8.51% below the 52-week high and 49.25% above the 52-week low. Over the last 10 years, it has returned 461.29%.

The company’s largest guru shareholder is

172 Views    Tiziano Frateschi    2019-10-01 18:50
Insiders inveseted in Bausch Health Companies, SmileDirectClub, Church & Dwight, Liberty TripAdvisor Holdings and Athenex

According to GuruFocus insider data, these are the largest CEO buys over the past week.

Bausch Health Companies CEO bought 30,000 shares

Bausch Health Companies Inc. (BHC) Chairman and CEO Joseph C. Papa bought 30,000 shares on Sept. 13 for an average price of $23.31. The stock has declined 1.93% since then.

The global specialty pharmaceutical company focuses on branded products for the dermatology, gastrointestinal and ophthalmology markets. The company also has a branded generics business that operates primarily in Latin America, Eastern Europe and Asia. The company has a market cap of $8.03 billion. Its shares traded around $22.86

124 Views    Joy Hu    2019-09-22 19:44
Insiders invest in Cigna, Bausch Health, At Home Group, Aerie Pharmaceuticals and REV Group

According to GuruFocus insider data, these are the largest CEO buys of the past week.

Cigna CEO bought 32,509 shares

Cigna Corp. (CI) President and CEO David Cordani bought 32,509 shares on Sept. 9 for an average price of $155.17. The share price has increased by 3.66% since then.

Cigna is one of the largest managed-care organizations in the U.S., with a little over 14 million medical members. It provides health insurance services to individuals mainly through the group (employer) market The company has a market cap of $60.74 billion. Its shares traded at $160.85 with a price-earnings ratio

84 Views    Joy Hu    2019-09-16 14:46
At Nintai, it's simply not possible to reduce risk enough where you are totally comfortable with your investment. Here's a case to show you why.

All men make mistakes, but a good man yields when he knows his course is wrong, and repairs the evil. The only sin is pride.” - Sophocles

It is the highest form of self-respect to admit our errors and mistakes and make amends for them. To make a mistake is only an error in judgment, but to adhere to it when it is discovered shows infirmity of character.” - Dale Turner

Over the course of my investing career, I’ve made some terrible investments. I’ve written about them before. In one, I talked about the general concept of looking

728 Views    Thomas Macpherson    2019-08-30 14:37
Concentration can be a winning strategy, as long as you don't concentrate on the wrong stock

The investing process is all about trade-offs, or compromises. One of those critical trade-offs is between concentration and diversification. You might earn more by concentrating on a small number of stocks, but if one or more of those stocks in which you concentrated goes bad, your whole portfolio will look grimmer.

That’s one of the principles behind index investing, for buying a cross-section of the market. Active managers are not paid to deliver what are essentially indexing results, however, so most focus on a limited number of high-potential stocks.

Chapter 11 of Michael Batnick’s book, “Big Mistakes: The Best Investors

606 Views    Robert Abbott    2019-06-27 21:15
Some insight into the Australian fund manager's investment process

I recently read an interview with Australian hedge fund manager John Hempton in the spring issue of Graham & Doddsville, the magazine compiled, edited and published by students at Columbia Business School.

I highly recommend going and having a look at the interview if you have time as Hempton provides a great discussion about what he looks for when searching for potential investments and why he is looking for companies that are a "small part of a big thing."

A skilled manager

Hempton has a unique take on finding longs, but he's perhaps better known for his shorts. One

206 Views    Rupert Hargreaves    2019-06-25 18:32
Reviewing the guru's portfolio changes

One of the many institutional investors I like to keep an eye on is Glenn Greenberg (Trades, Portfolio). I first came across Greenberg several years ago when writing a profile about him for another investment website, and have been interested in his process ever since.

Greenberg first started managing money in 1984, when he founded Chieftain Capital Management with his partner, John Shapiro. Greenberg and Shapiro employed a traditional value strategy, looking for undervalued equities on a cash basis.

There were, however, two primary differences between the investment strategy Chieftain employed and that the rest of the

495 Views    Rupert Hargreaves    2019-06-12 19:24
Ross Stores makes the list

According to the GuruFocus All-in-One Screener, the following companies have high business predictability ratings and a wide margin of safety.

Bausch Health Companies Inc. (BHC)

The company has a 3.5-star business predictability rank and, according to the discounted cash flow calculator, a 75.40% margin of safety at $21.11 per share.

The specialty pharmaceutical company has a market cap of $7.4 billion. Over the last five years, its revenue has grown 10.3%.

The stock has fallen 15.59% over the last 12 months and is currently trading with a forward price-earnings ratio of 5.09 and a price-book

175 Views    Tiziano Frateschi    2019-06-06 19:19
Kroger tops the list

According to the GuruFocus All-in-One Screener, the following companies have high business predictability ratings and a wide margin of safety.

The Kroger Co. (KR)

The company has a five-star business predictability rank and, according to the discounted cash flow calculator, a 76.27% margin of safety at $25 share.

1480281936.png

The retailer has a market cap of $19.96 billion and an enterprise value of $34.71 billion. Over the last five years, its revenue has grown 8.80%, and its earnings per share have increased 16.50%.

Over the last 12 months the price was stable and are

158 Views    Tiziano Frateschi    2019-04-30 16:28

Headlines Total 41
  • 1

2020-09-18 $ 17.38 (2.96%)
8:03pm
7:18pm
2020-09-08 $ 16.13 (-0.98%)
4:12pm
2020-09-05
10:31am
2020-09-04 $ 16.29 (2%)
4:38pm
2020-08-14 $ 17.48 (1.69%)
4:38pm
2020-08-09
6:26am
2020-08-07 $ 18.05 (-10.33%)
9:48am
2020-08-06 $ 20.13 (3.44%)
10:39am
8:05am
2020-08-05 $ 19.46 (2.47%)
9:45am
2020-08-03 $ 19.13 (4.71%)
12:09pm
2020-07-30 $ 18.85 (-1%)
11:33am
2020-07-03 $ 18.34 (%)
6:15am
2020-06-25 $ 18.99 (2.32%)
5:20pm
2020-06-22 $ 19.64 (0.31%)
12:53pm
2020-06-11 $ 17.02 (-9.37%)
2:23pm
2020-06-06
10:31am
2020-05-13 $ 16.37 (-4.6%)
5:35am
2020-05-08 $ 16.81 (5.92%)
5:43pm
9:26am
2020-05-07 $ 15.87 (-7.3%)
4:39pm
2:27pm
7:45am
2020-05-06 $ 17.12 (2.03%)
7:49am
2020-04-30 $ 18.12 (-1.47%)
11:34am
7:44am
2020-04-21 $ 16.24 (-5.8%)
11:32am
2020-04-14 $ 18.36 (2.91%)
8:55am
2020-04-13 $ 17.84 (-0.94%)
9:01am
2020-04-06 $ 14.62 (9.84%)
4:21pm
2020-04-01 $ 13.75 (-11.29%)
7:40am
2020-03-30 $ 15.25 (5.1%)
12:37pm
12:07pm
2020-03-12 $ 18.45 (-4.7%)
8:15pm
2020-02-17 $ 27.74 (%)
1:38pm
2019-11-14 $ 27.75 (1.35%)
3:38pm
12:38pm
2019-11-13 $ 27.38 (1.37%)
10:38am
2019-09-14 $ 23.24 (-2.15%)
10:15pm
2019-04-05 $ 25.12 (0.64%)
11:18am
Total 41
  • 1